Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$998K Sell
2,757
-863
-24% -$295K 0.01% 200
2026
Q1
$1.27M Sell
3,620
-999
-22% -$356K 0.02% 185
2025
Q4
$1.52M Buy
4,619
+1,746
+61% +$554K 0.02% 173
2025
Q3
$787K Sell
2,873
-22
-0.8% -$6.38K 0.01% 221
2025
Q2
$808K Sell
2,895
-11
-0.4% -$3.12K 0.01% 209
2025
Q1
$905K Sell
2,906
-43
-1% -$12.7K 0.02% 199
2024
Q4
$769K Buy
2,949
+19
+0.6% +$5.64K 0.01% 205
2024
Q3
$944K Buy
2,930
+27
+0.9% +$8.83K 0.02% 197
2024
Q2
$907K Buy
2,903
+34
+1% +$9.99K 0.02% 177
2024
Q1
$816K Buy
2,869
+5
+0.2% +$1.46K 0.02% 196
2023
Q4
$825K Buy
+2,864
New +$780K 0.02% 188

Other funds holding AMGN

Sapient Capital's AMGN Position: Q2 2026 in Review

Sapient Capital reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $295K and leaving 2,757 shares worth $998K. The position accounts for 0.01% of the portfolio, ranked #200.

Sapient Capital first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.52M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sapient Capital held 2,757 shares of Amgen worth $998K as of Q2 2026.
  • Sapient Capital sold 863 Amgen shares in Q2 2026, an estimated $295K.
  • Amgen made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #200 holding.
  • Sapient Capital first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Amgen position peaked at $1.52M in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.